See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / Alex Vellor

Author: Alex Vellor
09:26am, Wednesday, Dec 18, 2024
Novo Holdings Acquires Catalent for $16.5 Billion: What This Means for Pharma Stocks and Traders
Novo Holdings has acquired Catalent for $16.5 billion, expanding its influence in contract drug manufacturing. This strategic move could enhance revenue growth for Novo Nordisk and present new trading opportunities amid shifting market dynamics.
Read More